1-3 of 3
Stephane Picard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Use of therapeutic drug monitoring in CML patients on imatinib

François-Xavier Mahon, Stéphane Picard, Gerald Marit, Philip Robinson, Mathieu Molimard
Journal: Blood
Blood (2007) 110 (5): 1701.
https://doi.org/10.1182/blood-2007-04-087874
Published: 2007
Journal Articles

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

Clinical Trials & Observations Brief Report
Stephane Picard, Karine Titier, Gabriel Etienne, Emmanuelle Teilhet, Dominique Ducint, Marie-Agnes Bernard, Regis Lassalle, Gerald Marit, Josy Reiffers, Bernard Begaud, Nicholas Moore, Mathieu Molimard, Francois-Xavier Mahon
Journal: Blood
Blood (2006) 109 (8): 3496–3499.
https://doi.org/10.1182/blood-2006-07-036012
Published: 2006
Journal Articles

Trough Plasma Imatinib Concentrations Are Associated with Both Cytogenetic and Molecular Responses to Standard-Dose Imatinib in Chronic Myeloid Leukemia.

Stephane Picard, MD, Karine Titier, Pharm D, Gabriel Etienne, MD, Regis Lassalle, MSc, Gerald Marit, MD, Josy Reiffers, MD, Bernard Begaud, MD, Nicholas Moore, MD,PhD, Mathieu Molimard, MD,PhD, Francois-Xavier Mahon, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2141.
https://doi.org/10.1182/blood.V108.11.2141.2141
Published: 2006